Stay updated on Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial

Sign up to get notified when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record now presents details of AstraZeneca’s completed Phase 3 dapagliflozin study in people aged 10–24 with type 2 diabetes, including eligibility, study locations, interventions, outcomes, and record dates. It also provides publication, data-sharing, and study-document information.
    Difference
    66%
    Check dated 2026-11-10T16:48:41.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-11-03T16:54:27.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    A banner announcing NIH’s terminology transition was added above the ClinicalTrials.gov page. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:43:29.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:14:19.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study details and attached documents with a standard error page. This indicates an access restriction rather than a content update to the record.
    Difference
    18%
    Check dated 2026-09-22T22:32:41.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous v3.6.6. This appears to reflect a platform or template update rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-09-15T22:09:47.000Z thumbnail image

Stay in the know with updates to Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.